These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23973311)

  • 1. Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway.
    Fukuyama K; Tanahashi S; Hoshikawa M; Shinagawa R; Okada M
    Neuropharmacology; 2014 Jan; 76 Pt A():137-45. PubMed ID: 23973311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites.
    Fukuyama K; Okada M
    Br J Pharmacol; 2018 Nov; 175(22):4253-4265. PubMed ID: 30153331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine Attenuates Astroglial L-Glutamate Release Induced by Pro-Inflammatory Cytokines via Chronically Activation of Adenosine A
    Okada M; Fukuyama K; Shiroyama T; Ueda Y
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
    Yamamura S; Ohoyama K; Nagase H; Okada M
    Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New prospects for antipsychotic treatment - the role of the kynurenine pathway].
    Karakuła-Juchnowicz H; Flis M; Szymona K; Kuczyńska M; Stelmach E; Kowal-Popczak A
    Psychiatr Pol; 2014; 48(6):1167-77. PubMed ID: 25717486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis.
    Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati PJ; Brew BJ
    Redox Rep; 2000; 5(2-3):108-11. PubMed ID: 10939285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of the hyperdirect pathway of basal ganglia in a rodent brain slice.
    Bosch C; Mailly P; Degos B; Deniau JM; Venance L
    Neuroscience; 2012 Jul; 215():31-41. PubMed ID: 22537846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17():47. PubMed ID: 27130315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
    Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
    J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Group II/III metabotropic glutamate receptors attenuates LPS-induced astroglial neurotoxicity via promoting glutamate uptake.
    Zhou F; Yao HH; Wu JY; Yang YJ; Ding JH; Zhang J; Hu G
    J Neurosci Res; 2006 Aug; 84(2):268-77. PubMed ID: 16752416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity.
    Lopez S; Jouve L; Turle-Lorenzo N; Kerkerian-Legoff L; Salin P; Amalric M
    Neurobiol Dis; 2012 Apr; 46(1):69-77. PubMed ID: 22245662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenine pathway in Parkinson's disease-An update.
    Venkatesan D; Iyer M; Narayanasamy A; Siva K; Vellingiri B
    eNeurologicalSci; 2020 Dec; 21():100270. PubMed ID: 33134567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic glutamate receptors modulate glutamatergic and GABAergic synaptic transmission in the central nucleus of the inferior colliculus.
    Farazifard R; Wu SH
    Brain Res; 2010 Apr; 1325():28-40. PubMed ID: 20153735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenine metabolism in Alzheimer's disease.
    Baran H; Jellinger K; Deecke L
    J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors.
    Fazio F; Lionetto L; Curto M; Iacovelli L; Copeland CS; Neale SA; Bruno V; Battaglia G; Salt TE; Nicoletti F
    Neuropharmacology; 2017 Jan; 112(Pt B):365-372. PubMed ID: 27342123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia.
    Chen W; Tian Y; Gou M; Wang L; Tong J; Zhou Y; Feng W; Li Y; Chen S; Liu Y; Wang Z; Pan S; Zhang P; Huang J; Yang X; Li CR; Tian L; Hong LE; Tan Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110926. PubMed ID: 38147973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
    Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
    FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.